In Conversation

Switzerland Pharma Report June 2021
Latest Reports
Switzerland Pharma Report June 2021
- 2021
Switzerland continues to hold its own as a focal point for innovation and discovery in global medical science and ranks very highly on the radar of both Big Pharma and the international biotech community alike. As well as Switzerland’s continuing relevance to the European and global pharma industry, pharma is truly at the core of the Swiss economy, generating a full 5.4 percent of the country’s GDP, a number which rises to 9.2 percent when indirect effects are factored in. Moreover, the industry now accounts for a massive 45 percent of Switzerland’s total exports. This exclusive and wide-ranging new…
Switzerland Pharma Report February 2021
Latest Reports
Switzerland Pharma Report February 2021
- 2021
Switzerland, long held up as an innovation powerhouse able to hold its own against the considerably larger neighbouring life science markets of France and Germany, has, in some respects, found the going tougher of late. The country’s domestic drug market has been enduring a sticky patch and could only muster a modest growth rate of 2.8 percent in 2020 as policymakers grappled with issues more familiar to the rest of the continent such as cost-containment. Nonetheless, the country’s life science companies continue to achieve global acclaim and attract the attention of investors the world over.   As one of…
Switzerland Pharma Report
Latest Reports
Switzerland Pharma Report
- 2018
This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country  located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical companies in Novartis and Roche, and with a number one ranking globally in terms of ease of doing business and innovation. Switzerland is truly a healthcare and life sciences powerhouse. The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Swiss healthcare and pharma sectors.
Switzerland Pharma Report
Latest Reports
Switzerland Pharma Report
- 2017
This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country  located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical companies in Novartis and Roche, and with a number one ranking globally in terms of ease of doing business and innovation. Switzerland is truly a healthcare and life sciences powerhouse. The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Swiss healthcare and pharma sectors.
Switzerland Pharma Report
Latest Reports
Switzerland Pharma Report
- 2016
This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country  located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical companies in Novartis and Roche, and with a number one ranking globally in terms of ease of doing business and innovation. Switzerland is truly a healthcare and life sciences powerhouse. The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Swiss healthcare and pharma sectors.
We use cookies to ensure that we give you the best experience on our site. For more info click here